What is the icd 9 code for seasonal allergies

VAERS ID: 367430 BeforeAfter
VAERS Form:
Age: 49.0
Sex: Female
Location: North Carolina
Vaccinated: 2009-11-10
Onset: 2009-11-10
Submitted: 2009-11-11
Entered: 2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU(H1N1):INFLUENZA (H1N1) (INFLUENZA A (H1N1) 2009 MONOVALENT)INFLUENZA (H1N1) (H1N1 (MONOVALENT) (NOVARTIS)) / NOVARTIS VACCINES AND DIAGNOSTICS 102046P1 / 0 LA / IM

isteredby:Other Purchasedby:Private
Symptoms: Angioedema, Bronchospasm, Chest discomfort, Dyspnoea, Hypersensitivity, Paraesthesia, Pharyngeal oedema, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: UN~Influenza (Seasonal) (no brand name)~UN~0.00~Sibling
Other Medications:
Current Illness: None
Preexisting Conditions: Opiods, DEMEROL.

PMH: allergic rhinitis, asthma, breast palpation mass, dyspnea, endometriosis, morbid obesity Allergies: Ceclor, Demerol, Lorcet Plus, Morphine, Septra
Allergies:
Diagnostic Lab Data: None
CDC ‘Split Type’:

Write-up: Approximately 5-10 minutes after H1N1 vaccination istered, patient complains of tightening in throat and was short of breath. EPI PEN dose and Dyphenhydramine istered, patient much improved. 11/20/09 Medical records received for DOS 11/10/FInal DX: allergic reaction to influenza vaccine Immediately s/p vaccine developed tingling in arm, chest tight, throat swelling.

Bronchospasm, angioedema. Resolved. ICD9 Code: 995.27



Changed on 4/14/2017

VAERS ID: 367430 BeforeAfter
VAERS Form:
Age: 49.0
Sex: Female
Location: North Carolina
Vaccinated: 2009-11-10
Onset: 2009-11-10
Submitted: 2009-11-11
Entered: 2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU(H1N1): INFLUENZA (H1N1) (H1N1 (MONOVALENT) (NOVARTIS)) / NOVARTIS VACCINES AND DIAGNOSTICS 102046P1 / 0 LA / IM

isteredby:Other Purchasedby:Private
Symptoms:Angioedema, Bronchospasm, Chest discomfort, Dyspnoea, Hypersensitivity, Paraesthesia, Pharyngeal oedema, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: UN~Influenza (Seasonal) (no brand name)~UN~0.00~Sibling
Other Medications:
Current Illness: None
Preexisting Conditions: Opiods, DEMEROL.

PMH: allergic rhinitis, asthma, breast palpation mass, dyspnea, endometriosis, morbid obesity Allergies: Ceclor, Demerol, Lorcet Plus, Morphine, Septra
Allergies:
Diagnostic Lab Data: None
CDC ‘Split Type’:

Write-up: Approximately 5-10 minutes after H1N1 vaccination istered, patient complains of tightening in throat and was short of breath. EPI PEN dose and Dyphenhydramine istered, patient much improved.

11/20/09 Medical records received for DOS 11/10/FInal DX: allergic reaction to influenza vaccine Immediately s/p vaccine developed tingling in arm, chest tight, throat swelling. Bronchospasm, angioedema. Resolved. ICD9 Code: 995.27



First Appeared on 12/8/2009

VAERS ID: 367430
VAERS Form:
Age: 49.0
Sex: Female
Location: North Carolina
Vaccinated: 2009-11-10
Onset: 2009-11-10
Submitted: 2009-11-11
Entered: 2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU(H1N1): INFLUENZA (H1N1) (INFLUENZA A (H1N1) 2009 MONOVALENT) / NOVARTIS VACCINES AND DIAGNOSTICS 102046P1 / 0 LA / IM

isteredby:Other Purchasedby:Private
Symptoms: Angioedema, Bronchospasm, Chest discomfort, Dyspnoea, Hypersensitivity, Paraesthesia, Pharyngeal oedema, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: UN~Influenza (Seasonal) (no brand name)~UN~0.00~Sibling
Other Medications:
Current Illness: None
Preexisting Conditions: Opiods, DEMEROL.

PMH: allergic rhinitis, asthma, breast palpation mass, dyspnea, endometriosis, morbid obesity Allergies: Ceclor, Demerol, Lorcet Plus, Morphine, Septra
Allergies:
Diagnostic Lab Data: None
CDC ‘Split Type’:

Write-up: Approximately 5-10 minutes after H1N1 vaccination istered, patient complains of tightening in throat and was short of breath. EPI PEN dose and Dyphenhydramine istered, patient much improved. 11/20/09 Medical records received for DOS 11/10/FInal DX: allergic reaction to influenza vaccine Immediately s/p vaccine developed tingling in arm, chest tight, throat swelling.

Bronchospasm, angioedema. Resolved. ICD9 Code: 995.27



Common ICD-10 Pediatrics Codes

  1. Pain in Limb
  2. Chest Pain
  3. Acute Pharyngitis
  4. Abdominal Pain
  5. Routine Kid Health Examination
  6. Otitis Media
  7. Allergic Inflammation of the Nasal Airways
  8. Asthma
  9. Headache
  10. Diabetes Mellitus (Select)
  11. Acute Bronchitis
  12. Urinary Tract Infection, Cystitis

Otitis media, Unspecified

(ICD-9-CM 382.9)

H66.90* Otitis media, unspecified, unspecified ear
H66.91* Otitis media, unspecified, correct ear
H66.92* Otitis media, unspecified, left ear
H66.93* Otitis media, unspecified, bilateral

Chronic Mucoid Otitis Media

(ICD-9-CM 381.20, 381.29)

H65.30* Chronic mucoid otitis media, unspecified ear
H65.31 Chronic mucoid otitis media, correct ear
H65.32 Chronic mucoid otitis media, left ear
H65.33 Chronic mucoid otitis media, bilateral

Other Chronic Nonsuppurative Otitis Media

(ICD-9-CM 381.3)

H65.411 Chronic allergic otitis media, correct ear
H65.412 Chronic allergic otitis media, left ear
H65.413 Chronic allergic otitis media, bilateral
H65.419* Chronic allergic otitis media, unspecified ear
H65.491 Other chronic nonsuppurative otitis media, correct ear
H65.492 Other chronic nonsuppurative otitis media, left ear
H65.493 Other chronic nonsuppurative otitis media, bilateral
H65.499* Other chronic nonsuppurative otitis media, unspecified ear

Diabetes Mellitus (Select)

(ICD-9-CM 250.00 to 250.03 range)

E10.65 Type 1 diabetes mellitus with hyperglycemia
E10.9 Type 1 diabetes mellitus without complications
E11.65 Type 2 diabetes mellitus with hyperglycemia
E11.9 Type 2 diabetes mellitus without complications

Acute Bronchitis

(ICD-9-CM 466.0, 466.11, 466.19)
[Note: Organisms should be specified where possible]

J20.0 Acute bronchitis due to Mycoplasma pneumoniae
J20.1 Acute bronchitis due to Hemophilus influenzae
J20.2 Acute bronchitis due to streptococcus
J20.3 Acute bronchitis due to coxsackievirus
J20.4 Acute bronchitis due to parainfluenza virus
J20.5 Acute bronchitis due to respiratory syncytial virus
J20.6 Acute bronchitis due to rhinovirus
J20.7 Acute bronchitis due to echovirus
J20.8 Acute bronchitis due to other specified organisms
J20.9* Acute bronchitis, unspecified

Pain in Limb

(ICD-9-CM 729.5)

M79.601 Pain in correct arm
M79.602 Pain in left arm
M79.603* Pain in arm, unspecified
M79.604 Pain in correct leg
M79.605 Pain in left leg
M79.606* Pain in leg, unspecified
M79.609 Pain in unspecified limb
M79.621 Pain in correct upper arm
M79.622 Pain in left upper arm
M79.629* Pain in unspecified upper arm
M79.631 Pain in correct forearm
M79.632 Pain in left forearm
M79.639* Pain in unspecified forearm
M79.641 Pain in correct hand
M79.642 Pain in left hand
M79.643* Pain in unspecified hand
M79.644 Pain in correct finger(s)
M79.645 Pain in left finger(s)
M79.646* Pain in unspecified finger(s)
M79.651 Pain in correct thigh
M79.652 Pain in left thigh
M79.659* Pain in unspecified thigh
M79.661 Pain in correct lower leg
M79.662 Pain in left lower leg
M79.669* Pain in unspecified lower leg
M79.671 Pain in correct foot
M79.672 Pain in left foot
M79.673* Pain in unspecified foot
M79.674 Pain in correct toe(s)
M79.675 Pain in left toe(s)
M79.676* Pain in unspecified toe(s)

Otitis Media in Diseases Classified Elsewhere

(ICD-9-CM 382.02)

H67.1 Otitis media in diseases classified elsewhere, correct ear
H67.2 Otitis media in diseases classified elsewhere, left ear
H67.3 Otitis media in diseases classified elsewhere, bilateral
H67.9* Otitis media in diseases classified elsewhere, unspecified ear

Chest Pain

(ICD-9-CM 786.50 TO 786.59 range)

R07.1 Chest pain on breathing

R07.2 Precordial pain
R07.81 Pleurodynia
R07.82 Intercostal pain
R07.89 Other chest pain
R07.9* Chest pain, unspecified

Headache

(ICD-9-CM 784.0)

R51 Headache

Other Chronic Suppurative Otitis Media

(ICD-9-CM 382.3)

H66.3X1 Other chronic suppurative otitis media, correct ear
H66.3X2 Other chronic suppurative otitis media, left ear
H66.3X3 Other chronic suppurative otitis media, bilateral
H66.3X9* Other chronic suppurative otitis media, unspecified ear

Suppurative Otitis Media, Unspecified

(ICD-9-CM 382.4)

H66.40* Suppurative otitis media, unspecified, unspecified ear
H66.41* Suppurative otitis media, unspecified, correct ear
H66.42* Suppurative otitis media, unspecified, left ear
H66.43* Suppurative otitis media, unspecified, bilateral

Other Acute Nonsuppurative Otitis Media

(ICD-9-CM 381.00, 381.02 to 381.06 range)

H65.111 Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), correct ear
H65.112 Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), left ear
H65.113 Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), bilateral
H65.114 Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), recurrent, correct ear
H65.115 Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), recurrent, left ear
H65.116 Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), recurrent, bilateral
H65.117* Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), recurrent, unspecified ear
H65.119* Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous), unspecified ear
H65.191 Other acute nonsuppurative otitis media, correct ear
H65.192 Other acute nonsuppurative otitis media, left ear
H65.193 Other acute nonsuppurative otitis media, bilateral
H65.194 Other acute nonsuppurative otitis media, recurrent, correct ear
H65.195 Other acute nonsuppurative otitis media, recurrent, left ear
H65.196 Other acute nonsuppurative otitis media, recurrent, bilateral
H65.197* Other acute nonsuppurative otitis media recurrent, unspecified ear
H65.199* Other acute nonsuppurative otitis media, unspecified ear

Asthma

(ICD-9-CM 493.00, 493.01, 493.02, 493.10, 493.11, 493.12, 493.20, 493.21, 493.22, 493.81, 493.82 , 493.90, 493.91, 493.92)

J45.20 Mild intermittent asthma, uncomplicated
J45.21 Mild intermittent asthma with (acute) exacerbation
J45.22 Mild intermittent asthma with status asthmaticus
J45.30 Mild persistent asthma, uncomplicated
J45.31 Mild persistent asthma with (acute) exacerbation
J45.32 Mild persistent asthma with status asthmaticus
J45.40 Moderate persistent asthma, uncomplicated
J45.41 Moderate persistent asthma with (acute) exacerbation
J45.42 Moderate persistent asthma with status asthmaticus
J45.50 Severe persistent asthma, uncomplicated
J45.51 Severe persistent asthma with (acute) exacerbation
J45.52 Severe persistent asthma with status asthmaticus
J45.901* Unspecified asthma with (acute) exacerbation
J45.902* Unspecified asthma with status asthmaticus
J45.909* Unspecified asthma, uncomplicated
J45.990 Exercise induced bronchospasm
J45.991 Cough variant asthma
J45.998 Other asthma

Routine Kid Health Examination

(ICD-9-CM V20.2)

Z00.121 Encounter for routine kid health examination with abnormal findings
Z00.129 Encounter for routine kid health examination without abnormal findings

Acute Suppurative Otitis Media

(ICD-9-CM 382.00, 382.01)

H66.001 Acute suppurative otitis media without spontaneous rupture of ear drum, correct ear
H66.002 Acute suppurative otitis media without spontaneous rupture of ear drum, left ear
H66.003 Acute suppurative otitis media without spontaneous rupture of ear drum, bilateral
H66.004 Acute suppurative otitis media without spontaneous rupture of ear drum, recurrent, correct ear
H66.005 Acute suppurative otitis media without spontaneous rupture of ear drum, recurrent, left ear
H66.006 Acute suppurative otitis media without spontaneous rupture of ear drum, recurrent, bilateral
H66.007* Acute suppurative otitis media without spontaneous rupture of ear drum, recurrent, unspecified ear
H66.009* Acute suppurative otitis media without spontaneous rupture of ear drum, unspecified ear
H66.011 Acute suppurative otitis media with spontaneous rupture of ear drum, correct ear
H66.012 Acute suppurative otitis media with spontaneous rupture of ear drum, left ear
H66.013 Acute suppurative otitis media with spontaneous rupture of ear drum, bilateral
H66.014 Acute suppurative otitis media with spontaneous rupture of ear drum, recurrent, correct ear
H66.015 Acute suppurative otitis media with spontaneous rupture of ear drum, recurrent, left ear
H66.016 Acute suppurative otitis media with spontaneous rupture of ear drum, recurrent, bilateral
H66.017* Acute suppurative otitis media with spontaneous rupture of ear drum, recurrent, unspecified ear
H66.019* Acute suppurative otitis media with spontaneous rupture of ear drum, unspecified ear

Chronic Atticoantral Suppurative Otitis Media

(ICD-9-CM 382.2)

H66.20* Chronic atticoantral suppurative otitis media, unspecified ear
H66.21 Chronic atticoantral suppurative otitis media, correct ear
H66.22 Chronic atticoantral suppurative otitis media, left ear
H66.23 Chronic atticoantral suppurative otitis media, bilateral

Allergic Inflammation of the Nasal Airways

(ICD-9-CM 477.0 TO 477.9 range)

J30.0 Vasomotor rhinitis
J30.1 Allergic rhinitis due to pollen
J30.2 Other seasonal allergic rhinitis
J30.5 Allergic rhinitis due to food
J30.81 Allergic rhinitis due to animal (cat) (dog) hair and dander
J30.89 Other allergic rhinitis
J30.9* Allergic rhinitis, unspecified

Unspecified Nonsuppurative Otitis Media

(ICD-9-CM 381.4)

H65.90* Unspecified nonsuppurative otitis media, unspecified ear
H65.91* Unspecified nonsuppurative otitis media, correct ear
H65.92* Unspecified nonsuppurative otitis media, left ear
H65.93* Unspecified nonsuppurative otitis media, bilateral

Chronic Serous Otitis Media

(ICD-9-CM 381.10, 381.19)

H65.20* Chronic serous otitis media, unspecified ear
H65.21 Chronic serous otitis media, correct ear
H65.22 Chronic serous otitis media, left ear
H65.23 Chronic serous otitis media, bilateral

Acute Serous Otitis Media

(ICD-9-CM 381.01)

H65.00* Acute serous otitis media, unspecified ear
H65.01 Acute serous otitis media, correct ear
H65.02 Acute serous otitis media, left ear
H65.03 Acute serous otitis media, bilateral
H65.04 Acute serous otitis media, recurrent, correct ear
H65.05 Acute serous otitis media, recurrent, left ear
H65.06 Acute serous otitis media, recurrent, bilateral
H65.07* Acute serous otitis media, recurrent, unspecified ear

Acute Pharyngitis

(ICD-9-CM 034.0, 462)

J02.0 Streptococcal pharyngitis
J02.8 Acute pharyngitis due to other specified organisms
J02.9* Acute pharyngitis, unspecified

Chronic Tubotympanic Suppurative Otitis Media

(ICD-9-CM 382.1)

H66.10* Chronic tubotympanic suppurative otitis media, unspecified
H66.11 Chronic tubotympanic suppurative otitis media, correct ear
H66.12 Chronic tubotympanic suppurative otitis media, left ear
H66.13 Chronic tubotympanic suppurative otitis media, bilateral

Abdominal Pain

(ICD-9-CM 789.00 to 789.09 range)

R10.0 Acute abdomen
R10.10 Upper abdominal pain, unspecified
R10.11 Correct upper quadrant pain
R10.12 Left upper quadrant pain
R10.13 Epigastric pain
R10.2 Pelvic and perineal pain
R10.30 Lower abdominal pain
R10.31 Correct lower quadrant pain
R10.32 Left lower quadrant pain
R10.33 Periumbilical pain
R10.84 Generalized abdominal pain
R10.9* Unspecified abdominal pain

Urinary Tract Infection, Cystitis

(ICD-9-CM 595.0 to 595.4 range, 595.81, 595.82, 595.89, 595.9, 599.0)

N30.00 Acute cystitis without hematuria
N30.01 Acute cystitis with hematuria
N30.10 Interstitial cystitis (chronic) without hematuria
N30.11 Interstitial cystitis (chronic) with hematuria
N30.20 Other chronic cystitis without hematuria
N30.21 Other chronic cystitis with hematuria
N30.30 Trigonitis without hematuria
N30.31 Trigonitis with hematuria
N30.40 Irradiation cystitis without hematuria
N30.41 Irradiation cystitis with hematuria
N30.80 Other cystitis without hematuria
N30.81 Other cystitis with hematuria
N30.90 Cystitis, unspecified without hematuria
N30.91 Cystitis, unspecified with hematuria
N39.0* Urinary tract infection, site not specified

*Codes with a greater degree of specificity should be considered first.

Spring is in the air: CPT codes for allergies

April 10th, 2019 / By Kelly Endless, CPC

Spring is in the air: the birds are chirping, the trees are starting to bud and the pollen count is increasing, bringing with it the dreaded springtime allergy season.

Allergy facts:

  1. Symptoms of seasonal allergic rhinitis happen in spring, summer and early drop.

    They are generally caused by allergic sensitivity to pollens from trees, grasses or weeds, or to airborne mold spores.

  2. Allergic rhinitis, often called hay fever, is a common condition that causes symptoms such as sneezing, stuffy nose, runny nose, watery eyes and itching of the nose, eyes or the roof of the mouth.
  3. Allergies are the 6th leading cause of chronic illness in the U.S. with an annual cost of $18 billion. More than 50 million Americans suffer from allergies each year.
  4. Allergic rhinitis can be seasonal or perennial.
  5. Once diagnosed, allergic rhinitis treatment options are: avoidance, eliminating or decreasing your exposure to the irritants or allergens that trigger your symptoms, medication and immunotherapy (allergy shots).

To reduce your exposure to the things that trigger your allergies:

  1. If high pollen counts are forecasted, be proactive and start taking allergy medications before your symptoms begin.
  2. Don’t hang laundry outside—pollen can stick to sheets and towels which you then inadvertently bring indoors.
  3. Hand off lawn mowing, weed pulling and other yard work chores that stir up allergens to those that do not suffer from allergies.
  4. Stay indoors on dry, windy days.

    The best time to go exterior is after a excellent rain, which helps clear that pesky pollen from the air.

  5. Close doors and windows at night or any other time when pollen counts are high.
  6. Check the internet for pollen forecasts and current pollen levels or turn on your local news station for pollen forecasts which are often shown with the weather report.
  7. Remove clothes you’ve worn exterior and shower to rinse pollen from your skin and hair.
  8. Avoid outdoor activity in the early morning when pollen counts are at their peak.

When it does come time to see your physician for those allergy symptoms that just won’t ease up, the testing codes are as follows:

  1. 95060: Ophthalmic mucous membrane tests
  2. 95028: Intracutaneous (intradermal) tests with allergenic extracts, delayed type reaction, including reading, specify number of tests
  3. 95018: Allergy testing, any combination of percutaneous (scratch, puncture, prick) and intracutaneous (intradermal), sequential and incremental, with drugs or biologicals, immediate type reaction, including test interpretation and report, specify number of tests
  4. 95004: Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests
  5. 95065: Direct nasal mucous membrane test
  6. 95056: Photo tests
  7. 95024: Intracutaneous (intradermal) tests with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests
  8. 95027: Intracutaneous (intradermal) tests, sequential and incremental, with allergenic extracts for airborne allergens, immediate type reaction, including test interpretation and report, specify number of tests
  9. 95052: Photo patch test(s) (specify number of tests)
  10. 95044: Patch or application test(s) (specify number of tests)
  11. 95017: Allergy testing, any combination of percutaneous (scratch, puncture, prick) and intracutaneous (intradermal), sequential and incremental, with venoms, immediate type reaction, including test interpretation and report, specify number of tests
  12. 95199: Unlisted allergy/clinical immunologic service or procedure

There are various options to treat allergic rhinitis.

Medications can be used to treat seasonal allergies, nasal symptoms and itchy and watery eyes.

What is the icd 9 code for seasonal allergies

Allergy immunotherapy can be effective for those who cannot get relief from the standard prescribed medications and over the counter options. Immunotherapy treatment can provide long-term benefit for people with allergies.

The CPT codes for allergy immunotherapy are as follows:

  1. 95144: Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, single dose vial(s) (specify number of vials)
  2. 95120: Professional services for allergen immunotherapy in prescribing physician’s office or institution, including provision of allergenic extract; single injection
  3. 95115: Professional services for allergen immunotherapy not including provision of allergenic extracts; single injection
  4. 95117: Professional services for allergen immunotherapy not including provision of allergenic extracts; two or more injections
  5. 95125: Professional services for allergen immunotherapy in prescribing physician’s office or institution, including provision of allergenic extract; two or more injections
  6. 95165: Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy; single or multiple antigens (specify number of doses)

I hope you every own a amazing spring and while you are enjoying the beautiful weather, take care of those allergies before they take a hold of you.

Kelly Long is a clinical development analyst with 3M Health Information Systems.

You May Also Like

This is VAERS ID 367430



Examination of asthma-related medication prescriptions

Given that asthma rates were elevated in our population compared with previous reports, we sought to more accurately determine asthma prevalence in our population by correlating ICD-9 codes with asthma-related medication prescriptions.

What is the icd 9 code for seasonal allergies

Our most stringent asthma condition inclusion criteria required the occurrence of at least two encounters after the first birthday with an asthma diagnosis code separated by at least six months, and the presence of prescriptions for one or more asthma medications on at least two separate dates. Based on these criteria, we estimated an asthma prevalence rate of 21.6 % in our birth cohort and 18.4 % in our cross-sectional cohort (Additional file 5: Table S5).

In a manual review of charts of 20 children meeting our ICD-9 code definition of asthma (two visits at least 6 months apart), 18 (90 %) were confirmed to own asthma. Of the 18 children with confirmed asthma, 2 (11 %) outgrew their asthma symptoms during the time they received treatment from our health system.

Age at diagnosis and overall incidence

The incidence of eczema, asthma, and rhinitis in each 6-month age strata of our birth cohort are shown in Table 2. The incidence of eczema during the first 5 years of life was 15.3 %, with a peak age at diagnosis between 0 and 5 months of life (7.3 %).

The incidence of asthma during the first 5 years of life was 22.4 %, with a peak age at diagnosis between 12 and 17 months (8.7 %). The incidence of rhinitis over the first 5 years of life was 17.2 %, with a peak age at diagnosis between 24 and 29 months (2.5 %).

The incidence of food allergy in each 6-month age strata is shown in Fig. 1. The incidence of at least one food allergy during the first 5 years of life was 8.2 %, with a peak age at diagnosis between 12 and 17 months of life (1.9 %). The incidence of peanut, milk, egg, and soy allergies over the first 5 years of life ranged from 1.1 to 3.4 %, with a peak age at diagnosis between 12 and 17 months for peanut or egg allergy and between 6 and 11 months for milk or soy allergy.

The incidence of shellfish allergy was 1.2 %, with a peak age at diagnosis between 24 and 29 months.

Cohort demographics

The demographic characteristics of patients in both cohorts are shown in Table 1.

What is the icd 9 code for seasonal allergies

Our patient population were found to be approximately 48 % white, 40 % black, and own a primarily non-Medicaid payer type. To determine the accuracy of our coded EMR data, a manual chart review was performed on a subset of charts. The percent confirmed diagnosis for every conditions studied was 92 % (Additional file 4: Table S4).

Prevalence

Prevalence of eczema, asthma, and rhinitis by age strata in our cross-sectional cohort is shown in Table 3. The prevalence of eczema across every ages in our cohort was 6.7 %, with the peak prevalence between 3 and 5 years of life (7.7 %). The prevalence of asthma across every ages in our cohort was 21.8 %, with the peak prevalence between 14 and 17 years of age (23.0 %).

What is the icd 9 code for seasonal allergies

The prevalence of rhinitis across every ages in our cohort was 19.9 %, with the peak prevalence between 14 and 17 years (24.8 %). As a sensitivity analysis to assess the potential impact of alternative disease definitions, we utilized a subset of our cross-sectional cohort with at least 24 months of follow-up (n = 296,556) to identify those children whose eczema, asthma, and rhinitis diagnoses were present in at least two separate care visits occurring two or more years apart. The prevalence of eczema, asthma, and rhinitis did not substantially change when we required diagnosis codes to be present for at least two separate care visits occurring at least two years apart (7.1, 20.7, and 18.2 %, respectively).

Prevalence of food allergies by category and age strata in our cross-sectional cohort is shown in Fig.

2. The prevalence of at least one food allergy across every ages in our cohort was 6.7 %, with the peak prevalence between 0 and 3 years of life (5.7 %). Peanut allergy was most common (2.6 %), followed by milk (2.2 %), egg (1.8 %), shellfish (1.5 %), and soy (0.7 %). Milk, egg, and soy allergy were most common between 0 and 3 years of age (2.6, 2.1, and 0.8 % respectively), while peanut allergy was most common between 3 and 5 years (2.1 %) and shellfish allergy was most common between 14 and 17 years (1.6 %).

Food allergy as a risk factor for respiratory allergy

Prior studies own suggested that patients with food allergy are at increased risk of developing asthma, however, these studies relied on participant reporting, were relatively little, or were limited to a single outcome [16, 18].

Utilizing our birth cohort, we sought to investigate the extent to which healthcare provider-diagnosed food allergy placed children at risk for developing respiratory allergy (asthma or rhinitis). The prevalence of asthma in patients with food allergy is shown in Table 4. Of patients with an established diagnosis of food allergy, 35 % went on to develop asthma (adjusted odds ratio: 2.16, 95 % CI: 1.94-2.4). Of the major food allergens, allergy to peanut, milk, and egg significantly predisposed to developing asthma (OR 1.74, 1.38, and 1.60, respectively).

Additionally, patients with multiple food allergies were at increased risk of developing asthma as compared to patients with a single food allergy (Table 4).

The prevalence of rhinitis in patients with food allergy is shown in Table 5. Of patients with an established diagnosis of food allergy, 35 % went on to develop rhinitis (adjusted odds ratio: 2.72, 95 % CI: 2.45-3.03). Of the major food allergens, allergy to peanut, milk, and egg significantly predisposed to developing rhinitis (OR 2.59, 1.46, and 1.80, respectively). Additionally, patients with multiple food allergies were at increased risk of developing rhinitis as compared to patients with a single food allergy (Table 5).

Ahead of Print

Original Articles

VEGF -2549 -2567 del18 polymorphism and irreversible bronchoconstriction in asthmatics
Gomulka K, Liebhart J, Jaskula E, Lange A, Medrala W
J Investig Allergol Clin Immunol 2019; Vol.

29(6)
doi: 10.18176/jiaci.0369
[summary][PDF full-Text]

IgE-mediated sensitization to galactose-alpha-1,3-galactose (a-gal) in urticaria and anaphylaxis in Spain: geographical variations and risk factors
Mateo-Borrega MB, Garcia B, Hernando Larramendi C, Azofra J, González-Mancebo E, Alvarado MI, Alonso Díaz de Durana MD, Núñez-Orjales R, Diéguez MC, Guilarte M, Soriano-Galarraga AM, Sosa G, Ferrer A, García-Moral A, Beristain AM, Bartra J
J Investig Allergol Clin Immunol 2019; Vol.

29(6)
doi: 10.18176/jiaci.0373
[summary][PDF full-Text][Supplemental Materials]

Incidence and risk factors of low-osmolar iodinated contrast media related immediate hypersensitivity reactions: A longitudinal study based on a real-time monitoring system
Suh-Young L, Dong Yoon K, Ju-Young K, Soon Ho Y, Young-Hoon C, Whal L, Sang Heon C, Hye-Ryun K
J Investig Allergol Clin Immunol 2019; Vol. 29(6)
doi: 10.18176/jiaci.0374
[summary][PDF full-Text]

Relevance of Th2 markers in the assessment and therapeutic management of severe allergic asthma: a genuine life perspective
Caminati M, Vianello A, Chieco Bianchi F, Festi G, Guarnieri G, Marchi MR, Micheletto C, Olivieri M, Tognella S, Guerriero M, Senna G, NEONET Study Group
J Investig Allergol Clin Immunol 2020; Vol.

30(1)
doi: 10.18176/jiaci.0379
[summary][PDF full-Text]

Clinical factors associated with the overuse of asthma save medication
Urrutia I, Delgado J, Domínguez-Ortega J, Mascarós E, Pérez M, Resler G, Plaza V, on behalf on the MISTRAL Investigators Group
J Investig Allergol Clin Immunol 2020; Vol. 30(1)
doi: 10.18176/jiaci.0387
[summary][PDF full-Text]

Omalizumab’s effectiveness in severe allergic asthma and nasal polyps: a real-life study
Tiotiu A, Oster JP, Roux P, Nguyen Thi PL, Peiffer G, Bonniaud P, Dalphin JC, de Blay F
J Investig Allergol Clin Immunol 2020; Vol.

30(1)
doi: 10.18176/jiaci.0391
[summary][PDF full-Text]

General anesthetics drug challenge tests: predictive worth of skin tests
Tornero Molina P, Rojas-Perez-Ezquerra P, Noguerado-Mellado B, Baeza Ochoa de Ocáriz ML, Garrido Sánchez A, Alonso Mateos M, Zubeldia Ortuño JM
J Investig Allergol Clin Immunol 2020; Vol. 30(2)
doi: 10.18176/jiaci.0402
[summary][PDF full-Text][Supplemental Materials]

Promoter genotyping and mRNA expression analysis of PTGDR gene in allergy
San Segundo-Val I, García-Sánchez A, Sanz C, Cornejo-García JA, Isidoro-García M, Dávila I
J Investig Allergol Clin Immunol 2020; Vol.

30(2)
doi: 10.18176/jiaci.0411
[summary][PDF full-Text][Supplemental Materials]

Atopic dermatitis phenotypes in preschool and school-age children: a latent class analysis
Galli E, Maiello N, Cipriani F, La Grutta S, Fasola S, Carello R, Caminiti L, Licari A, Landi M, Di Mauro D, Ricci G, Panel of the Italian Society of Pediatric Allergy and Immunology (SIAIP)
J Investig Allergol Clin Immunol 2020; Vol. 30(2)
doi: 10.18176/jiaci.0409
[summary][PDF full-Text][Supplemental Materials]

Subcutaneous immunotherapy with high-dose cat and dog extracts: a real-life study
Uriarte SA, Sastre J
J Investig Allergol Clin Immunol 2020; Vol.

30(3)
doi: 10.18176/jiaci.0415
[summary][PDF full-Text]

Adaptation to Spanish and validation of the Rhinitis Control Assessment Test (RCAT) questionnaire
Del Cuvillo A, Sastre J, Colás C, Navarro AM, Mullol J, Valero A
J Investig Allergol Clin Immunol 2020; Vol. 30(3)
doi: 10.18176/jiaci.0420
[summary][PDF full-Text]

FOXP3 expression, vitamins D and C in the prediction of tolerance acquisition in infants with cow’s milk allergy
Sardecka I, Łoś-Rycharska E, Gawryjołek J, Toporowska – Kowalska E, Krogulska A
J Investig Allergol Clin Immunol 2020; Vol.

30(3)
doi: 10.18176/jiaci.0422
[summary][PDF full-Text][Supplemental Materials]

Does Rapid Drug Desensitization to chemotherapy affect survival outcomes?
Berges-Gimeno MP, Carpio-Escalona LV, Longo-Muñoz F, Bernal-Rubio L, Lopez-Gonzalez P, Gehlhaar P, Pachon V, Ferreiro-Monteagudo R, Madrigal-Burgaleta R, Alvarez-Cuesta E
J Investig Allergol Clin Immunol 2020; Vol. 30(4)
doi: 10.18176/jiaci.0425
[summary][PDF full-Text]

Main contributory factors on asthma control and health-related quality of life (QoL) in elderly asthmatics
Enríquez-Matas A, Fernández Rodríguez C, Andrés Esteban EM, Fernández Crespo J
J Investig Allergol Clin Immunol 2020; Vol.

30(4)
doi: 10.18176/jiaci.0430
[summary][PDF full-Text]

Molecular diagnosis in home dust mite allergic patients suggests clinical relevance of Der p 23 in asthmatic children
Jiménez-Feijoo R, Pascal M, Moya R, Riggioni C, Domínguez O, Lózano J, Álvaro-Lozano M, Piquert M, Machinena A, Folque M, Dias M, Carnés J, Plaza AM
J Investig Allergol Clin Immunol 2020; Vol. 30(2)
doi: 10.18176/jiaci.0431
[summary][PDF full-Text]

The safety and efficacy of aspirin desensitization combined with long-term aspirin therapy in Aspirin-exacerbated respiratory disease
Renjiao L, Fengming L
J Investig Allergol Clin Immunol 2020; Vol.

30(5)
doi: 10.18176/jiaci.0433
[summary][PDF full-Text]

Immunochemical and physical quantitation of grass and olive pollen allergens and correlation with asthma admitions in Cáceres, Spain
Porcel Carreño S, Gómez Nieves E, Fernández-Caldas E, Abel Fernández E, Cases B, Tudela JI, Maghfour Martin Y, Domínguez Domínguez E, Alvarado Arenas M, Jiménez Timón S, Ahmida T, García Ponce JF, Jiménez Gallardo P, Alvarado Izquierdo MI, Hernández Arbeiza J
J Investig Allergol Clin Immunol 2020; Vol.

30(5)
doi: 10.18176/jiaci.0434
[summary][PDF full-Text]

Contribution of recombinant Parvalbumin Gad c 1 in the diagnosis and prognosis of fish allergy
Carvalho S, Marcelino J, Cabral Duarte M, Costa C, Barbosa M, Pereira Dos Santos MC
J Investig Allergol Clin Immunol 2020; Vol. 30(5)
doi: 10.18176/jiaci.0437
[summary][PDF full-Text]

Molecular allergen profiling of dual mite sensitization in severe allergic rhinitis
González-Pérez R, Pineda F, Poza-Guedes P, Castillo M, Matheu V, Sánchez-Machín I
J Investig Allergol Clin Immunol 2020; Vol.

30(6)
doi: 10.18176/jiaci.0439
[summary][PDF full-Text]

Quality of Life and characterization of patients with atopic dermatitis in Portugal — QUADEP study
Carvalho D, Aguiar P, Mendes-Bastos P, Palma-Carlos A, Freitas J, Ferrinho P
J Investig Allergol Clin Immunol 2020; Vol. 30(6)
doi: 10.18176/jiaci.0443
[summary][PDF full-Text]

Paediatric Barcelona Olfactory Test-6 (pBOT-6): Validation of a Combined Odour Identification and Threshold Screening Test in Healthy Spanish Children and Adolescents
Mariño-Sánchez F, Valls-Mateus M, Fragola C, de los Santos G, Aguirre A, Alonso J, Valero J, Santamaría A, Rojas Lechuga MJ, Cobeta I, Alobid I, Mullol J
J Investig Allergol Clin Immunol 2020; Vol.

30(6)
doi: 10.18176/jiaci.0451
[summary][PDF full-Text]

Farm environment during pregnancy and childhood and polysensitization at the age of 31 — Prospective birth cohort study in Finland
Karvonen AM, Lampi J, Keski Nisula L, Auvinen J, Toppila Salmi S, Järvelin MR, Pekkanen J
J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0455
[summary][PDF full-Text][Supplemental Materials]

A Comprehensive Prospective Study of Costs Associated to the Evaluation of beta-lactam Allergy
Sobrino García M, Muñoz Bellido FJ, Moreno E, Macías E, Gracia Bara MT, Laffond E, Lázaro Sastre M, Martín García C, de Arriba Méndez S, Campanón Toro MV, Gallardo Higueras A, Dávila I
J Investig Allergol Clin Immunol 2021; Vol.

31(1)
doi: 10.18176/jiaci.0457
[summary][PDF full-Text][Supplemental Materials]

Angiotensin-converting enzyme inhibitor-associated angioedema in a cohort of Caucasian patients: from bed to bench
Carucci L, Bova M, Petraroli A, Ferrara AL, Sutic A, de Crescenzo G, Cordisco G, Margaglione M, Gambardella J, Spadaro G, Genovese A, Loffredo S
J Investig Allergol Clin Immunol 2020; Vol. 30(4)
doi: 10.18176/jiaci.0458
[summary][PDF full-Text]

Assessing Adherence by Combining the Test of Adherence to Inhalers with Pharmacy Refill Records
Plaza V, Giner J, Curto E, Alonso Ortiz MB, Orue MI, Vega JM, Cosío BG, Group of investigators of the RE-TAI study
J Investig Allergol Clin Immunol 2021; Vol.

31(1)
doi: 10.18176/jiaci.0461
[summary][PDF full-Text][Supplemental Materials]

Association between severity of anaphylaxis and coexistence of respiratory diseases: a systematic review and meta-analysis of observational studies
Farias-Aquino E, Tejedor-Alonso MA, Pérez-Fernández E, Moro-Moro M, Rosado-Ingelmo A, Alberti Masgrau N, Pérez-Codesido S, Privitera-Torres M
J Investig Allergol Clin Immunol 2021; Vol. 31(2)
doi: 10.18176/jiaci.0462
[summary][PDF full-Text]

Factors affecting the success of step-up therapy in patients with moderate-severe asthma: a real-life study
Delgado J, Martinez-Moragón E, Fernández-Sánchez T
J Investig Allergol Clin Immunol 2021; Vol.

What is the icd 9 code for seasonal allergies

31(2)
doi: 10.18176/jiaci.0470
[summary][PDF full-Text]

SEAIC Specialty Forum: analysis of the current situation of allergology in Spain and its future outlook
Sastre Domínguez J, Valero Santiago A, Montoro Lacomba J, Quirce S, Vidal Pan C, Dávila González I, Olaguibel Rivera JM, Torres Jaén MJ, Rodríguez Vázquez V, Antolin Amerigo D, Ojeda Fernández P, Investigators from a study group
J Investig Allergol Clin Immunol 2021; Vol. 31(2)
doi: 10.18176/jiaci.0473
[summary][PDF full-Text][Supplemental Materials]

Anaphylaxis to Vespa velutina nigrithorax: pattern of sensitization for an emerging problem in Western countries
Vidal C, Armisén M, Monsalve R, González-Vidal T, Lojo S, López-Freire S, Méndez P, Rodríguez V, Romero L, Galán A, González-Quintela A
J Investig Allergol Clin Immunol 2021; Vol.

What is the icd 9 code for seasonal allergies

31(3)
doi: 10.18176/jiaci.0474
[summary][PDF full-Text]

Clinical features and disease management of adult patients with atopic dermatitis receiving care at reference hospitals in Brazil: the ADAPT Study
Karla Arruda L, Campos Yang A, Aoki V, Fachini Jardim Criado R, Cezar Pires M, Lupi O, Helder Zambaldi Fabricio L, Abreu D, Silvi S
J Investig Allergol Clin Immunol 2021; Vol. 31(3)
doi: 10.18176/jiaci.0478
[summary][PDF full-Text]

HAE-AS, a specific disease activity scale for hereditary angioedema with C1-inhibitor deficiency
João Forjaz M, Ayala A, Caminoa M, Prior N, Pérez-Fernández E, Caballero T, on behalf of the DV-HAE-QoL study group
J Investig Allergol Clin Immunol 2021; Vol.

31(3)
doi: 10.18176/jiaci.0479
[summary][PDF full-Text][Supplemental Materials]

PAGE Study: Summary of a study protocol to estimate the prevalence of severe asthma in Spain using big-data methods
Almonacid Sánchez C, Melero Moreno C, Quirce Gancedo S, Sánchez-Herrero MG, Álvarez Gutiérrez FJ, Bañas Conejero D, Cardona V, Soriano JB
J Investig Allergol Clin Immunol 2021; Vol. 31(4)
doi: 10.18176/jiaci.0483
[summary][PDF full-Text]

Low expression of ICAM-1 in blood eosinophils in patients with athletic eosinophilic esophagitis
Pérez-Lucendo I, Gómez Torrijos E, Donado P, Melero R, Feo-Brito F, Urra JM
J Investig Allergol Clin Immunol 2021; Vol.

31(4)
doi: 10.18176/jiaci.0489
[summary][PDF full-Text]

Guidelines

Referral criteria for asthma: Consensus document
Blanco Aparicio M, Delgado Romero J, Molina París J, Gómez Sáenz JT, Gómez Ruiz F, Álvarez Gutiérrez FJ, Domínguez Ortega J, Núñez Palomo S, Hidalgo Requena A, Vargas Ortega DA, Álvarez Puebla MJ, Carretero Gracia JA
J Investig Allergol Clin Immunol 2020; Vol. 30(2)
doi: 10.18176/jiaci.0393
[summary][PDF full-Text]

Spanish Guidelines for Diagnosis, Management, Treatment and Prevention of DRESS syndrome
Cabañas R, Ramírez E, Sendagorta E, Alamar R, Barranco R, Blanca-López N, Doña I, Fernández J, Garcia-Nunez I, García-Samaniego J, Lopez-Rico R, Marín-Serrano E, Mérida C, Moya C, Ortega-Rodríguez NR, Rivas Becerra B, Rojas-Perez-Ezquerra P, Sánchez-González MJ, Vega-Cabrera C, Vila-Albelda C, Bellón T
J Investig Allergol Clin Immunol 2020; Vol.

30(4)
doi: 10.18176/jiaci.0480
[summary][PDF full-Text][Supplemental Materials]

Review

Action Plan to Reach the Global Availability of Adrenaline Auto-Injectors
Kase Tanno L, Demoly P, and on behalf of the Joint Allergy Academies
J Investig Allergol Clin Immunol 2019; Vol. 29(6)
doi: 10.18176/jiaci.0346
[summary][PDF full-Text]

Common Variable Immunodeficiency: Epidemiology, Pathogenesis, Clinical manifestations, Diagnosis, Classification and Management
Yazdani R, Habibi S, Sharifi L, Azizi G, Abolhassani H, Olbrich P, Aghamohammadi A
J Investig Allergol Clin Immunol 2020; Vol.

30(1)
doi: 10.18176/jiaci.0388
[summary][PDF full-Text]

What we know about fish allergy by the finish of the decade?
Kourani E, Corazza F, Michel O, Doyen V
J Investig Allergol Clin Immunol 2020; Vol. 30(1)
doi: 10.18176/jiaci.0381
[summary][PDF full-Text]

Diagnostic Approach for Suspected Allergic Cutaneous Reaction to a Permanent Tattoo
Silvestre JF, González-Villanueva I
J Investig Allergol Clin Immunol 2019; Vol.

29(6)
doi: 10.18176/jiaci.0383
[summary][PDF full-Text]

Ebastine in the treatment of allergic rhinitis and urticaria: 30 years of clinical studies and real-world experience
Sastre J
J Investig Allergol Clin Immunol 2020; Vol. 30(3)
doi: 10.18176/jiaci.0401
[summary][PDF full-Text]

Position Statement of the Spanish Society of Allergology and Clinical Immunology on Provocation Tests with Aspirin/Nonsteroidal anti-inflammatory drugs
Izquierdo Domínguez A, Bobolea I, Doña I, Campo P, Segura C, Ortega N, González R, Delgado J, Torres MJ, Dordal MT, and Behalf of the SEAIC Rhinoconjunctivitis Committee
J Investig Allergol Clin Immunol 2020; Vol.

30(5)
doi: 10.18176/jiaci.0449
[summary][PDF full-Text]

Practitioner’s Corner

Allergy to Spathiphyllum wallisii, an indoor allergen
Herrera-Lasso Regás V, Dalmau Duch G, Gázquez García V, Pineda De La Losa F, Castillo Fernández M, Garnica Velandia D, Gaig Jané P
J Investig Allergol Clin Immunol 2019; Vol. 29(6)
doi: 10.18176/jiaci.0419
[summary][PDF full-Text]

Celiac disease and wheat allergy may coexist: two case reports
Lombardi C, Savi E, Passalacqua G
J Investig Allergol Clin Immunol 2019; Vol.

29(6)
doi: 10.18176/jiaci.0421
[summary][PDF full-Text]

Survey of opinion of Spanish physicians on the role of eosinophils in asthma and other pathologies
Plaza V, Blanco M, Delgado J, Martínez I, Zubeldía JM, Molina J
J Investig Allergol Clin Immunol 2019; Vol. 29(6)
doi: 10.18176/jiaci.0423
[summary][PDF full-Text][Supplemental Materials]

Chronic Pulmonary Aspergillosis Succesfully Treated With Isavuconazole
Guillen-Vera D, Ruiz-Ruigómez M, García-Moguel I, Morales-Ruiz R, Corbella L, Fernández-Rodríguez C
J Investig Allergol Clin Immunol 2019; Vol.

29(6)
doi: 10.18176/jiaci.0424
[summary][PDF full-Text][Supplemental Materials]

Occupational asthma induced by quinoa exposure
Guarnieri G, Bonadonna P, Olivieri E, Schiappoli M
J Investig Allergol Clin Immunol 2019; Vol. 29(6)
doi: 10.18176/jiaci.0432
[summary][PDF full-Text][Supplemental Materials]

Chronic urticaria associated with occult papillary thyroid carcinoma and dramatic improvement after entire thyroidectomy: A retrospective study from Turkey
Özkaya E, Kılıç Sayar S, Mahmudov A
J Investig Allergol Clin Immunol 2019; Vol.

29(6)
doi: 10.18176/jiaci.0435
[summary][PDF full-Text]

Long-term remission of Wells syndrome with omalizumab
Coattrenec Y, Ibrahim LY, Harr T, Spoerl D, Jandus P
J Investig Allergol Clin Immunol 2020; Vol. 30(1)
doi: 10.18176/jiaci.0436
[summary][PDF full-Text]

Eosinophilic esophagitis during latex desensitization
Nucera E, Urbani S, Buonomo A, Andriollo G, Aruanno A
J Investig Allergol Clin Immunol 2020; Vol. 30(1)
doi: 10.18176/jiaci.0440
[summary][PDF full-Text]

Atopy can be an interfering factor in genetic association studies of beta-lactam allergy
Rivera Reigada ML, Moreno E, Sanz C, García-Sanchez A, Cornejo-García JA, Dávila I, Isidoro-García M
J Investig Allergol Clin Immunol 2020; Vol.

30(1)
doi: 10.18176/jiaci.0441
[summary][PDF full-Text][Supplemental Materials]

The method for selecting basophils might be determinant in the basophil activation test in patients with mastocytosis
Urra JM, Pérez Lucendo I, Extremera A, Feo Brito F, Alfaya T
J Investig Allergol Clin Immunol 2020; Vol. 30(1)
doi: 10.18176/jiaci.0442
[summary][PDF full-Text]

Cypress pollen allergy in a Mediterranean area
Castillo Marchuet MJ, Luengo O, Cardona V
J Investig Allergol Clin Immunol 2020; Vol.

30(1)
doi: 10.18176/jiaci.0444
[summary][PDF full-Text]

Rapid Drug Desensitization with Rituximab in 24 Cases: Single-Center Experience
Görgülü B, Cengiz Seval G, Kendirlinan R, Koçak Toprak S, Özcan M, Bavbek S
J Investig Allergol Clin Immunol 2019; Vol. 29(6)
doi: 10.18176/jiaci.0445
[summary][PDF full-Text][Supplemental Materials]

Occupational asthma and rhinitis due to yellow and red henna in a hairdresser
Villalobos V, Rial MJ, Pastor-Vargas C, Esteban I, Cuesta J, Sastre J
J Investig Allergol Clin Immunol 2020; Vol.

30(2)
doi: 10.18176/jiaci.0453
[summary][PDF full-Text]

Multiple drug hypersensitivity syndrome to anti-TB drugs. A case report
Carneiro-Leão L, Gomes I, Freitas C, Costa e Silva M, Viseu R, Cernadas J
J Investig Allergol Clin Immunol 2020; Vol. 30(1)
doi: 10.18176/jiaci.0446
[summary][PDF full-Text][Supplemental Materials]

Asthma apps use and interest among patients with asthma: a multicentre study
Jácome C, Almeida R, Pereira AM, Araújo L, Correia M, Pereira M, Couto M, Lopes C, Chaves Loureiro C, Catarata MJ, Santos LM, Ramos B, Mendes A, Pedro E, Cidrais Rodrigues JC, Oliveira G, Aguiar AP, Arrobas AM, Costa J, Dias J, Todo Bom A, Azevedo J, Ribeiro C, Alves M, Leiria Pinto P, Neuparth N, Palhinha A, Gaspar Marques J, Martins P, Trincão D, Neves A, Todo Bom F, Alvarenga Santos M, Branco J, Lozoya C, Costa A, Silva Neto A, Silva D, Vasconcelos MJ, Teixeira MF, Ferreira-Magalhães M, Taborda Barata L, Carvalhal C, Santos N, Pinto CS, Rodrigues Alves R, Moreira AS, Morais Silva P, Fernandes R, Ferreira R, Alves C, Câmara R, Ferraz de Oliveira J, Bordalo D, Calix MJ, Marques A, Nunes C, Menezes F, Gomes R, Almeida Fonseca J, INSPIRERS group
J Investig Allergol Clin Immunol 2020; Vol.

30(2)
doi: 10.18176/jiaci.0456
[summary][PDF full-Text][Supplemental Materials]

Fatal anaphylactic shock induced by intravenous gelatin colloid: An allergological postmortem work-up
Molina Molina GJ, Carrasco González MD, Viñas Giménez L, Sanz Martínez M, Galván Blasco P, Luengo O, Guilarte M, Sala Cunill A, Cardona V, Labrador Horrillo M
J Investig Allergol Clin Immunol 2020; Vol.

30(2)
doi: 10.18176/jiaci.0459
[summary][PDF full-Text]

Asthma, comorbidities, and aggravating circumstances. The GEMA-FORUM II task force
Trigueros JA, Plaza V, Domínguez Ortega J, Serrano J, Cisneros C, Padilla A, Antón Gironés M, Mosteiro M, Martínez Moragón E, Olaguíbel Rivera JM, Delgado J, García Rivero JL, Martínez Rivera C, Garrido JJ, Quirce S, GEMAFORUM task force
J Investig Allergol Clin Immunol 2020; Vol. 30(2)
doi: 10.18176/jiaci.0460
[summary][PDF full-Text][Supplemental Materials]

Tolerance to cephalosporins and carbapenems in penicillin allergic patients
Sánchez de Vicente J, Gamboa P, García-Lirio E, Irazabal B, Jáuregui I, Martínez MD, Segurola A, Seras Y, Galán C
J Investig Allergol Clin Immunol 2020; Vol.

30(1)
doi: 10.18176/jiaci.0463
[summary][PDF full-Text]

H1-antihistamines may be no longer necessary for patients with refractory chronic spontaneous urticaria after introduction of omalizumab treatment
Ensina LF, Arruda LK, Campos RA, Criado RFJ, Valle SOR, Melo JML, Oliveira JCS, Dortas-Junior SD, Cusato Ensina AP, Camelo Nunes IC, Agondi RC
J Investig Allergol Clin Immunol 2020; Vol. 30(2)
doi: 10.18176/jiaci.0464
[summary][PDF full-Text][Supplemental Materials]

Desquamating-nonpigmenting with onycholysis fixed drug eruption in a kid due to amoxicillin.

Cross-reactivity study
Moya B, Vera A, Bazire R, Betancor D, Rodríguez Del Río P, Escudero C, Ibáñez MD
J Investig Allergol Clin Immunol 2020; Vol. 30(2)
doi: 10.18176/jiaci.0466
[summary][PDF full-Text]

A new terminal nonsense mutation of Cathepsin C gene in a patient with atypical Papillon-Lefèvre Syndrome
Moura AL, Regateiro FS, Peres Resende E, Gonçalo M, Todo Bom A, Faria E
J Investig Allergol Clin Immunol 2020; Vol.

30(2)
doi: 10.18176/jiaci.0467
[summary][PDF full-Text]

Exhaled nitric oxide (eNO) measurements with the new evernoa® device, through a extended range of eNO levels, are valid and reproducible
Olaguibel A, Oleaga M, Iraola A, Cortaberría R, Corcuera A, Álvarez Puebla MJ, Tabar A, Ruete L, Botas A, Olaguibel JM
J Investig Allergol Clin Immunol 2020; Vol. 30(2)
doi: 10.18176/jiaci.0465
[summary][PDF full-Text][Supplemental Materials]

Long-Term Anti-Interleukin 5 Antibodies Treatment in a Patient with Chronic Eosinophilic Pneumonia
Shimizu Y, Kurosawa M, Sutoh Y, Sutoh E
J Investig Allergol Clin Immunol 2020; Vol.

30(2)
doi: 10.18176/jiaci.0468
[summary][PDF full-Text][Supplemental Materials]

Omalizumab in the treatment of Hyper-IgE Syndrome — 2 case reports
Gomes N, Miranda J, Lopes S, Carneiro-Leão L, Torres Costa J, Baudrier T, Azevedo F
J Investig Allergol Clin Immunol 2020; Vol. 30(3)
doi: 10.18176/jiaci.0469
[summary][PDF full-Text][Supplemental Materials]

Effects of Indoor Endocrine Disrupting Chemicals on Childhood Rhinitis
Paciência I, Cavaleiro Rufo J, Silva D, Mendes F, Farraia M, Delgado L, Padrão P, Moreira P, Severo M, Moreira A
J Investig Allergol Clin Immunol 2020; Vol.

What is the icd 9 code for seasonal allergies

30(3)
doi: 10.18176/jiaci.0471
[summary][PDF full-Text][Supplemental Materials]

Locust bean gum induced FPIES in infant
Jędrzejczyk M, Bartnik K, Funkowicz M, Toporowska-Kowalska E
J Investig Allergol Clin Immunol 2020; Vol. 30(3)
doi: 10.18176/jiaci.0475
[summary][PDF full-Text]

Oat Allergy: About two Cases
Tomás-Pérez M, Iglesias-Souto FJ, Bartolome B
J Investig Allergol Clin Immunol 2020; Vol. 30(3)
doi: 10.18176/jiaci.0477
[summary][PDF full-Text]

Dupilumab-associated conjunctivitis in patients with atopic dermatitis: a multicenter real-life experience
Nettis E, Bonzano L, Patella V, Detoraki C, Trerotoli P, Lombardo C, on behalf of the Italian DADReL study group
J Investig Allergol Clin Immunol 2020; Vol.

30(3)
doi: 10.18176/jiaci.0481
[summary][PDF full-Text][Supplemental Materials]

Occupational Rhinoconjunctivitis Induced by Unusual Allergens of Carrot
Sánchez-Guerrero IM, Nieto A, Meseguer J, Navarro M, López Sáez MP, Magdalena MK, Sánchez Pérez N, Pineda F, López Sánchez JD
J Investig Allergol Clin Immunol 2020; Vol. 30(3)
doi: 10.18176/jiaci.0482
[summary][PDF full-Text]

An unusual occupational rhinitis: a case report
Touati N, Chiriac AM, Bourrain JL, Demoly P
J Investig Allergol Clin Immunol 2020; Vol.

30(3)
doi: 10.18176/jiaci.0484
[summary][PDF full-Text]

Multidisciplinary Team Work to succeed: A Primary Immunodeficiency Unit experience
Barrios Y, Franco A, Alonso-Larruga A, Sánchez-Machín I, Poza-Guedes P, Gonzalez R, Matheu V
J Investig Allergol Clin Immunol 2020; Vol. 30(3)
doi: 10.18176/jiaci.0485
[summary][PDF full-Text]

Heterogenicity of the Allergen Content in Male Dog Urine and Dander
Calzada D, Iraola V, Carnés J
J Investig Allergol Clin Immunol 2020; Vol.

30(3)
doi: 10.18176/jiaci.0487
[summary][PDF full-Text][Supplemental Materials]

Multidisciplinary severe asthma management: The role of hospital pharmacists in accredited specialized asthma units for adults in Spain
Villamañán E, Herrero A, Álvarez-Sala R, Quirce S
J Investig Allergol Clin Immunol 2020; Vol. 30(4)
doi: 10.18176/jiaci.0488
[summary][PDF full-Text]

The clinical concepts for pediatrics guide includes common ICD-10 codes, clinical documentation tips and clinical scenarios.


Changed on 2/14/2017

VAERS ID: 367430 BeforeAfter
VAERS Form:
Age: 49.0
Sex: Female
Location: North Carolina
Vaccinated: 2009-11-10
Onset: 2009-11-10
Submitted: 2009-11-11
Entered: 2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU(H1N1):INFLUENZA (H1N1) (H1N1 (MONOVALENT) (NOVARTIS)INFLUENZA (H1N1) (H1N1 (MONOVALENT) (NOVARTIS)) / NOVARTIS VACCINES AND DIAGNOSTICS 102046P1 / 0 LA / IM

isteredby:Other Purchasedby:Private
Symptoms: Angioedema, Bronchospasm, Chest discomfort, Dyspnoea, Hypersensitivity, Paraesthesia, Pharyngeal oedema, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: UN~Influenza (Seasonal) (no brand name)~UN~0.00~Sibling
Other Medications:
Current Illness: None
Preexisting Conditions: Opiods, DEMEROL.

PMH: allergic rhinitis, asthma, breast palpation mass, dyspnea, endometriosis, morbid obesity Allergies: Ceclor, Demerol, Lorcet Plus, Morphine, Septra
Allergies:
Diagnostic Lab Data: None
CDC ‘Split Type’:

Write-up: Approximately 5-10 minutes after H1N1 vaccination istered, patient complains of tightening in throat and was short of breath. EPI PEN dose and Dyphenhydramine istered, patient much improved. 11/20/09 Medical records received for DOS 11/10/FInal DX: allergic reaction to influenza vaccine Immediately s/p vaccine developed tingling in arm, chest tight, throat swelling.

Bronchospasm, angioedema. Resolved.

What is the icd 9 code for seasonal allergies

ICD9 Code: 995.27



Changed on 7/12/2011

VAERS ID: 367430 BeforeAfter
VAERS Form:
Age: 49.0
Sex: Female
Location: North Carolina
Vaccinated: 2009-11-10
Onset: 2009-11-10
Submitted: 2009-11-11
Entered: 2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU(H1N1):INFLUENZA (H1N1) (H1N1 (MONOVALENT) (NOVARTIS))INFLUENZA (H1N1) (H1N1 (MONOVALENT) (NOVARTIS) / NOVARTIS VACCINES AND DIAGNOSTICS 102046P1 / 0 LA / IM

isteredby:Other Purchasedby:Private
Symptoms: Angioedema, Bronchospasm, Chest discomfort, Dyspnoea, Hypersensitivity, Paraesthesia, Pharyngeal oedema, Throat tightness

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations: UN~Influenza (Seasonal) (no brand name)~UN~0.00~Sibling
Other Medications:
Current Illness: None
Preexisting Conditions: Opiods, DEMEROL.

PMH: allergic rhinitis, asthma, breast palpation mass, dyspnea, endometriosis, morbid obesity Allergies: Ceclor, Demerol, Lorcet Plus, Morphine, Septra
Allergies:
Diagnostic Lab Data: None
CDC ‘Split Type’:

Write-up: Approximately 5-10 minutes after H1N1 vaccination istered, patient complains of tightening in throat and was short of breath. EPI PEN dose and Dyphenhydramine istered, patient much improved. 11/20/09 Medical records received for DOS 11/10/FInal DX: allergic reaction to influenza vaccine Immediately s/p vaccine developed tingling in arm, chest tight, throat swelling.

Bronchospasm, angioedema. Resolved. ICD9 Code: 995.27



RELATED VIDEO: